Zepbound®
$1,455.00 / month
Tirzepatide injectable, available as Zepbound®, is a revolutionary medication that targets two hormone receptors that aid in weight loss. This dual approach helps regulate blood sugar while enhancing insulin production, decreases appetite and increases satiety further enhancing weight loss. Tirzepatide dual action makes it an effective option for those who have not had success with existing therapies. Patients reported greater weight loss and fewer side effects than with a single action medication like Semaglutide.
Description
Tirzepatide is an injectable medication that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Both GIP and GLP-1 are hormones involved in regulating insulin secretion, appetite, and energy balance. By targeting both receptors, tirzepatide may offer enhanced effects on blood glucose control and weight loss compared to GLP-1 receptor agonists alone.
As with other drugs in this class, the most common side effects of tirzepatide are gastrointestinal in nature, including nausea, vomiting, diarrhea, and constipation. These side effects are usually dose-dependent and tend to decrease over time.
Tirzepatide should be used in conjunction with a reduced-calorie diet and increased physical activity. It should not be used in combination with other GLP-1 receptor agonists or drugs that contain Tirzepatide.
Kristoffer Barriteau –
Amazing Product, life changing. The Revolutionary Telehealth team is top tier!